Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Raises Price Target on Vertex Pharmaceuticals (VRTX); Company Remains 'Top Pick'
-
Piper Jaffray Maintains an 'Overweight' on Macrovision (MVSN); Raises Price Target
-
Piper Jaffray Reiterates an 'Overweight' on California Pizza Kitchen (CPKI); Raises Guidance
-
Seneca Foods (SENEA) Announces 3.7M Share Secondary Offering
-
Unusual 11 Mid-Day Movers 7/8: NVGN, GRVY, TRGT, AMGN Higher; ARYX, RODM, YRCW, GNW Lower
-
Notable Analyst Rating Changes 7/8: DRYS, FSLR, BBY, AMZN, FCX Upgraded; MGI, HOT, YGE, CHTT Downgraded
-
Morning Movers 7/8: TRGT, HNAB, AMGN, NTWK, FDO Higher; ARYX, XNPT, ARNA, AXL Lower
-
Arena Pharmaceuticals (ARNA) Prices 12.5M Shares at $4.17
-
Piper Jaffray Reiterates an 'Overweight' on Regeneron Pharmaceuticals (REGN); Raises Price Target
-
Piper Jaffray Downgrades MoneyGram International (MGI) to Underweight; Shares Overvalued
-
Munster Says Apple (AAPL) Will Have 'Good' Q3, but 'Huge' September and December Quarters
-
XTENT, Inc. (XTNT) Postpones Shareholder Meeting; Continues Strategic Evaluation With Piper Jaffray
-
Arena Pharmaceuticals (ARNA) To File Mixed Securities Shelf
-
Notable Analyst Rating Changes 7/7: INTC, KEY, KSS, MCO, MRVL Upgraded; HNSN, BJ, AMSG Downgraded
-
Piper Jaffray Upgrades Moody's (MCO) to Overweight; Raises Price Target & Estimates on Attractive Valuation
-
Piper Jaffray Initiates Coverage on Obagi Medical Products (OMPI) with an Overweight; Attractive at Current Levels
-
Piper Jaffray Initiates Coverage on Valeant Pharmaceuticals (VRX) with an Underweight; Valuation Based on Sum-of-the-Parts
-
Piper Jaffray Initiates Coverage on Salix Pharmaceuticals (SLXP) with an Overweight
-
Piper Jaffray Reiterates an 'Overweight' Rating on F5 Networks (FFIV); Raises Price Target
-
Sepracor (SEPR) Sinks After Another Pipeline Drug Fails
-
Unusual 11 Mid-Day Movers 7/1: OSK, BORL, UIS, SDTH Higher; BEAT, FRPT, RPRX, SPAR Lower
-
LogMeIn (LOGM) IPO Surges Higher
-
David Moenning's Daily State of the Markets: 7/1
-
Piper Jaffray Maintains an Overweight on XenoPort (XNPT); Price Target Increased
-
Piper Jaffray Initiates Coverage on Myriad Pharmaceuticals (MYRX) with an Underweight; Pipeline Lacks Sufficient Data
-
Piper Jaffray Transitions Coverage on Alvarion Ltd. (ALVR) to Underweight; Raises 2010 EPS Estimates
-
Piper Jaffray Transitions Rating on AtriCure (ATRC) to Underweight; Risk/Reward Less Attractive
-
LogMeIn (LOGM) IPO Prices at $16, High End of Range
-
Piper Jaffray Transfers Coverage on Myriad Genetics (MYGN) to Overweight; Attractive Opportunity At Present Levels
-
Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts
-
Coldwater Creek (CWTR) Surges on Piper Jaffray Buy Recommendation
-
Piper Jaffray Maintains Bullish Stance On GSI Commerce (GSIC)
-
Piper Jaffray Initiates Coverage on Coldwater Creek (CWTR) with a Buy; High Expectations May Present Investors With Buying Opportunity
-
Piper Jaffray Maintains a 'Neutral' on Mindray Medical (MR); Raises Prices Target & 2009 Estimates
-
Piper Jaffray Reiterates a 'Buy' on Wright Express (WXS); Raises Price Target & Estimates
-
Piper Jaffray Initiates Coverage on CommScope (CTV) with a Buy; Well Positioned to Benefit From Increased Capacity
-
Piper Jaffray Said Google (GOOG) Paid Click Data Tracking In-Line
-
Investors Cheer Oracle's (ORCL) Q4 Earnings, Analysts Remain Bullish
-
Duoyuan Global Water (DGW) IPO Surges Higher
-
Duoyuan Global Water (DGW) IPO Prices at $16
-
Chemspec International (CPC) IPO Trades Higher
-
Chemspec International (CPC) IPO Prices at $9, Top End of Range
-
Piper Jaffray Boosts Price Target on Brocade Comm (BRCD) to $10
-
Tim Cook Emerges As A Top Leader At Apple (AAPL)
-
Intel (INTC) Expected To Announce New Mobile Device With Nokia (NOK)
-
Piper Jaffray Downgrades Stratasys (SSYS) to Neutral; Domestic Checks Indicate Weak Demand
-
Four IPOs Slated To Open This Week (CPC, DGW, IVR, MDSO)
-
Analysts Weigh-In On Target (TGT) After Credit Card Master Trust Data
-
Piper Jaffray Calls Level 3's (LVLT) Debt Exchange "Positive", But Still Cautious
-
Piper Jaffray Downgrades Cytori Therapeutics (CYTX) to Sell
